Course Description
Dive into the complex interplay between hormones and mental health, understanding how natural hormone changes throughout the life cycle can impact psychiatric well-being. This presentation will explore the links between hormonal fluctuations and mental health disorders, shedding light on how endocrine changes may manifest as psychiatric symptoms. Learn to identify signs and symptoms related to the therapeutic use of exogenous hormones, enhancing your ability to provide holistic care in psychiatric practice.
Learning Objectives
- Describe how changes in endogenous hormones can influence premenstrual dysphoric disorder (PMDD).
- Explain the mechanism of allopregnanolone in both the pathophysiology and treatment of PMDD and postpartum depression
- Discuss the influence of estradiol on schizophrenia as it relates to women.
- Summarize current evidence on neuropsychiatric effects of hormonal contraception.
Target Audience
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
Faculty
View biographical information
Andrew Novick, MD, PhD
Assistant Professor, Department of Psychiatry, Medical Director – CU Esketamine Program,
Reproductive Psychiatrist – Center for Women’s Behavioral Health and Wellness
Aurora, CO
Dr Andrew Novick is an assistant professor of psychiatry at the University of Colorado School of Medicine. He received his Bachelor’s Degree in Pharmacology and Toxicology from the Philadelphia College of Pharmacy, and then went on to receive his dual MD/PHD degrees from the University of South Dakota. His doctoral work focused on the effects of adolescent social defeat stress on dopamine system dynamics and the use of selective dopamine and norepinephrine re-uptake inhibitors.
Following graduation, he became a research track resident in psychiatry at Brown University, where he made the transition to human research, with a focus on psychiatric consequences of early life stress. Simultaneously, he underwent training in reproductive psychiatry at the Women and Infants Hospital of Rhode Island which is home to the nation’s first Mother-Infant Psychiatric Partial Hospital Program.
Upon completing his residency in 2019, Dr Novick became faculty at the University of Colorado. As a clinician, he works as a reproductive psychiatrist and acts as medical director of the CU Esketamine Program. His research focuses on two main areas: 1) understanding the effects of sex steroids in the brain; and 2) evaluating novel drug therapeutics, especially psychedelics, for mood disorders. His major current projects include an NIH-funded clinical trial investigating the neurobiology of hormonal contraception, as well as a clinical trial using psilocybin for anhedonia in Major Depressive Disorder. When not striving to move the field of psychiatry forward, he can be found at home with his wife and their 3-year-old Belgian Malinois, Zipper Gore.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
Activity Dates: 04/29/2025 - 04/29/2028
ACPE Contact Hours: 1
ACPE Number: 0284-0000-25-017-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View disclaimer and disclosure of off-label use
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
View fair balance and integrity statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.